1 Ocak 2021 Dergi makalesi Açık Erişim

Palaz, Fahreddin; Kalkan, Ali Kerem; Can, Ozgur; Demir, Ayca Nur; Tozluyurt, Abdullah; Ozcan, Ahsen; Ozsoz, Mehmet

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="n">6</subfield>
    <subfield code="c">1245-1267</subfield>
    <subfield code="v">10</subfield>
    <subfield code="p">ACS SYNTHETIC BIOLOGY</subfield>
  </datafield>
  <controlfield tag="005">20221007104217.0</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:aperta.ulakbim.gov.tr:239840</subfield>
    <subfield code="p">user-tubitak-adresli-yayinlar</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey</subfield>
    <subfield code="a">Palaz, Fahreddin</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Over the past decades, significant progress has been made in targeted cancer therapy. In precision oncology, molecular profiling of cancer patients enables the use of targeted cancer therapeutics. However, current diagnostic methods for molecular analysis of cancer are costly and require sophisticated equipment. Moreover, targeted cancer therapeutics such as monoclonal antibodies and small-molecule drugs may cause off-target effects and they are available for only a minority of cancer driver proteins. Therefore, there is still a need for versatile, efficient, and precise tools for cancer diagnostics and targeted cancer treatment. In recent years, the CRISPR-based genome and transcriptome engineering toolbox has expanded rapidly. Particularly, the RNA-targeting CRISPR-Cas13 system has unique biochemical properties, making Cas13 a promising tool for cancer diagnosis, therapy, and research. Cas13-based diagnostic methods allow early detection and monitoring of cancer markers from liquid biopsy samples without the need for complex instrumentation. In addition, Cas13 can be used for targeted cancer therapy through degrading and manipulating cancer-associated transcripts with high efficiency and specificity. Moreover, Cas13-mediated programmable RNA manipulation tools offer invaluable opportunities for cancer research, identification of drug-resistance mechanisms, and discovery of novel therapeutic targets. Here, we review and discuss the current use and potential applications of the CRISPR-Cas13 system in cancer diagnosis, therapy, and research. Thus, researchers will gain a deep understanding of CRISPR-Cas13 technologies, which have the potential to be used as next-generation cancer diagnostics and therapeutics.</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
    <subfield code="a">Creative Commons Attribution</subfield>
  </datafield>
  <controlfield tag="001">239840</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-01-01</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-adresli-yayinlar</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Hacettepe Univ, Fac Pharm, TR-06100 Ankara, Turkey</subfield>
    <subfield code="a">Kalkan, Ali Kerem</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Koc Univ, Dept Mol Biol &amp; Genet, TR-34450 Istanbul, Turkey</subfield>
    <subfield code="a">Can, Ozgur</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Afyonkarahisar Hlth Sci Univ, Fac Med, TR-03100 Afyon, Turkey</subfield>
    <subfield code="a">Demir, Ayca Nur</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Hacettepe Univ, Fac Med, Dept Med Microbiol, TR-06100 Ankara, Turkey</subfield>
    <subfield code="a">Tozluyurt, Abdullah</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">TUBITAK Marmara Res Ctr, Inst Genet Engn &amp; Biotechnol, TR-41470 Kocaeli, Turkey</subfield>
    <subfield code="a">Ozcan, Ahsen</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Near East Univ, Dept Biomed Engn, Nicosia, Turkey</subfield>
    <subfield code="a">Ozsoz, Mehmet</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/239840/files/bib-b1a82c29-fd26-4949-9af4-4c48d72d9506.txt</subfield>
    <subfield code="s">227</subfield>
    <subfield code="z">md5:c8ecb3328d86c5127c6175f00c12da69</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1021/acssynbio.1c00107</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
</record>